To attack the credibility of the CEO you are invested in (still with me?), one has to start somewhere. Science? It’s not easy since CTIX is 4 for 4 in clinical trials so far.
The keyword here is “expected”. It’s an estimation. While the trials involving cancer patients are taking longer than expected, Leo has met the estimated completion date for B-ABSSSI and P.
I agree that it’s unrealistic to expect most/all estimated timelines to be met because clinical trials are very complex.